Afermine News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Afermine. Real-time updates on events, politics, business and more.

Seelos To Get License For Wafermine From IX Biopharma For $9 Mln

November 24, 2021

WASHINGTON (dpa-AFX) - Seelos Therapeutics, Inc. (SEEL), a company focused on the development of therapies for central nervous system disorders and rare diseases, said on Wednesday that it has

United States Hong Kong Raj Mehra Seelos Therapeutics Inc Ix Biopharma Ltd York Headquartered Seelos

Source: finanznachrichten.de

iX Biopharma Ltd: iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products

November 24, 2021

iX Biopharma will receive an initial US$9 million upfront payment Eligible for up to US$239 million in development and sales milestone payments Double digit royalties on future product

United States New York Hong Kong Raj Mehra Kostenloser Wertpapierhandel Yee Chia Hsing

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Afermine News Today

Seelos To Get License For Wafermine From IX Biopharma For $9 Mln

iX Biopharma Ltd: iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products

Explore More Categories